MEGIN is the global leader for Magnetoencephalography (MEG) technology, a non-invasive, functional brain mapping solution for the diagnostic workup, treatment strategy and intervention of neurological conditions. Through innovation and passionate exploration of the endless possibilities with MEG, specialists from close to one hundred sites from around the world have used our MEG technology to study pathological and eloquent areas of the brain in patients diagnosed with neurological disorders.
MEGIN Spotlight – Dr. Steve Allder, a Consultant Neurologist at Re:Cognition Health
MEGIN was delighted to welcome Re:Cognition Health’s Steve Allder, Brain and Mind Experts in the UK specializing in the diagnosis and treatment of a wide range of conditions, such as Autism, Alzheimer’s disease, Parkinson’s, and Traumatic Brain Injury utilizing MEG Technology during patient’s treatment plans. We discuss case studies in which MEG enabled patients to gain an insight into their current health situation and provide more clarity.